Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study - PubMed (original) (raw)

Multicenter Study

doi: 10.1136/bmj.e3397.

Sebastian Ott, Eveline Nüesch, Maximilian von Eynatten, Christian Schumann, Mathias W Pletz, Nicole M Mealing, Tobias Welte, Torsten T Bauer, Norbert Suttorp, Peter Jüni, Robert Bals, Gernot Rohde; German Community Acquired Pneumonia Competence Network

Collaborators, Affiliations

Multicenter Study

Serum glucose levels for predicting death in patients admitted to hospital for community acquired pneumonia: prospective cohort study

Philipp M Lepper et al. BMJ. 2012.

Abstract

Objective: To examine whether acute dysglycaemia predicts death in people admitted to hospital with community acquired pneumonia.

Design: Multicentre prospective cohort study.

Setting: Hospitals and private practices in Germany, Switzerland, and Austria.

Participants: 6891 patients with community acquired pneumonia included in the German community acquired pneumonia competence network (CAPNETZ) study between 2003 and 2009.

Main outcome measures: Univariable and multivariable hazard ratios adjusted for sex, age, current smoking status, severity of community acquired pneumonia using the CRB-65 score (confusion, respiratory rate >30/min, systolic blood pressure ≤ 90 mm Hg or diastolic blood pressure ≤ 60 mm Hg, and age ≥ 65 years), and various comorbidities for death at 28, 90, and 180 days according to serum glucose levels on admission.

Results: An increased serum glucose level at admission to hospital in participants with community acquired pneumonia and no pre-existing diabetes was a predictor of death at 28 and 90 days. Compared with participants with normal serum glucose levels on admission, those with mild acute hyperglycaemia (serum glucose concentration 6-10.99 mmol/L) had a significantly increased risk of death at 90 days (1.56, 95% confidence interval 1.22 to 2.01; P<0.001), and this risk increased to 2.37 (1.62 to 3.46; P<0.001) when serum glucose concentrations were ≥ 14 mmol/L. In sensitivity analyses the predictive value of serum glucose levels on admission for death was confirmed at 28 days and 90 days. Patients with pre-existing diabetes had a significantly increased overall mortality compared with those without diabetes (crude hazard ratio 2.47, 95% confidence interval 2.05 to 2.98; P<0.001). This outcome was not significantly affected by serum glucose levels on admission (P = 0.18 for interaction).

Conclusions: Serum glucose levels on admission to hospital can predict death in patients with community acquired pneumonia without pre-existing diabetes. Acute hyperglycaemia may therefore identify patients in need of intensified care to reduce the risk of death from community acquired pneumonia.

PubMed Disclaimer

Conflict of interest statement

Competing interests: All authors have completed the ICMJE uniform disclosure form at www.icmje.org/coi\_disclosure.pdf (available on request from the corresponding author) and declare: no support from any organisation for the submitted work; no financial relationships with any organisations that might have an interest in the submitted work in the previous three years; and no other relationships or activities that could appear to have influenced the submitted work.

Figures

None

Fig 1 Cumulative incidence of death (%) within 90 days in participants with community acquired pneumonia stratified by serum glucose levels on admission overall (n=6016) (top) and without diabetes (n=5141) (bottom). The 875 participants with missing data for serum glucose levels on admission were not included in these calculations for patients at risk

None

Fig 2 Cumulative incidence of death (%) within 90 days in participants with community acquired pneumonia with and without pre-existing diabetes (top) and without diabetes but stratified according to high or low serum glucose levels on admission (bottom)

None

Fig 3 Crude and adjusted analyses of cohorts with the highest mortality. Results from all 6891 participants after multiple imputation

References

    1. Aliberti S, Amir A, Peyrani P, Mirsaeidi M, Allen M, Moffett BK, et al. Incidence, etiology, timing, and risk factors for clinical failure in hospitalized patients with community-acquired pneumonia. Chest 2008;134:955-62. - PubMed
    1. Kornum JB, Thomsen RW, Riis A, Lervang HH, Schonheyder HC, Sorensen HT. Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study. Diabetes Care 2008;31:1541-5. - PMC - PubMed
    1. Seshasai SR, Kaptoge S, Thompson A, Di AE, Gao P, Sarwar N, et al. Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 2011;364:829-41. - PMC - PubMed
    1. Shah BR, Hux JE. Quantifying the risk of infectious diseases for people with diabetes. Diabetes Care 2003;26:510-3. - PubMed
    1. Abourizk NN, Vora CK, Verma PK. Inpatient diabetology. The new frontier. J Gen Intern Med 2004;19(5 Pt 1):466-71. - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources